UniProt ID | CPEB1_HUMAN | |
---|---|---|
UniProt AC | Q9BZB8 | |
Protein Name | Cytoplasmic polyadenylation element-binding protein 1 | |
Gene Name | CPEB1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 566 | |
Subcellular Localization | Cytoplasm . Nucleus . Cytoplasm, P-body. Cytoplasmic granule. Cell junction, synapse. Membrane. Cell junction, synapse, postsynaptic cell membrane, postsynaptic density. Cell projection, dendrite. Continuously shuttling between nucleus and cytoplasm | |
Protein Description | Sequence-specific RNA-binding protein that regulates mRNA cytoplasmic polyadenylation and translation initiation during oocyte maturation, early development and at postsynapse sites of neurons. Binds to the cytoplasmic polyadenylation element (CPE), an uridine-rich sequence element (consensus sequence 5'-UUUUUAU-3') within the mRNA 3'-UTR. RNA binding results in a clear conformational change analogous to the Venus fly trap mechanism. [PubMed: 24990967 In absence of phosphorylation and in association with TACC3 is also involved as a repressor of translation of CPE-containing mRNA; a repression that is relieved by phosphorylation or degradation (By similarity Involved in the transport of CPE-containing mRNA to dendrites; those mRNAs may be transported to dendrites in a translationally dormant form and translationally activated at synapses (By similarity Its interaction with APLP1 promotes local CPE-containing mRNA polyadenylation and translation activation (By similarity Induces the assembly of stress granules in the absence of stress. Required for cell cycle progression, specifically for prophase entry] | |
Protein Sequence | MALSLEEEAGRIKDCWDNQEAPALSTCSNANIFRRINAILDNSLDFSRVCTTPINRGIHDHLPDFQDSEETVTSRMLFPTSAQESSRGLPDANDLCLGLQSLSLTGWDRPWSTQDSDSSAQSSTHSVLSMLHNPLGNVLGKPPLSFLPLDPLGSDLVDKFPAPSVRGSRLDTRPILDSRSSSPSDSDTSGFSSGSDHLSDLISSLRISPPLPFLSLSGGGPRDPLKMGVGSRMDQEQAALAAVTPSPTSASKRWPGASVWPSWDLLEAPKDPFSIEREARLHRQAAAVNEATCTWSGQLPPRNYKNPIYSCKVFLGGVPWDITEAGLVNTFRVFGSLSVEWPGKDGKHPRCPPKGNMPKGYVYLVFELEKSVRSLLQACSHDPLSPDGLSEYYFKMSSRRMRCKEVQVIPWVLADSNFVRSPSQRLDPSRTVFVGALHGMLNAEALAAILNDLFGGVVYAGIDTDKHKYPIGSGRVTFNNQRSYLKAVSAAFVEIKTTKFTKKVQIDPYLEDSLCHICSSQPGPFFCRDQVCFKYFCRSCWHWRHSMEGLRHHSPLMRNQKNRDSS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MALSLEEEAGR ----CCCCHHHHHCC | 24.97 | 23612710 | |
43 | Phosphorylation | INAILDNSLDFSRVC HHHHHCCCCCHHHHC | 29.05 | 19690332 | |
52 | Phosphorylation | DFSRVCTTPINRGIH CHHHHCCCCCCCCHH | 19.62 | 21712546 | |
80 | Phosphorylation | TSRMLFPTSAQESSR HHHEECCCCHHHHHC | 29.38 | 24719451 | |
172 | Phosphorylation | VRGSRLDTRPILDSR CCCCCCCCCCCCCCC | 42.83 | - | |
178 | Phosphorylation | DTRPILDSRSSSPSD CCCCCCCCCCCCCCC | 30.53 | 25850435 | |
180 | Phosphorylation | RPILDSRSSSPSDSD CCCCCCCCCCCCCCC | 38.84 | 27732954 | |
181 | Phosphorylation | PILDSRSSSPSDSDT CCCCCCCCCCCCCCC | 45.20 | 27732954 | |
182 | Phosphorylation | ILDSRSSSPSDSDTS CCCCCCCCCCCCCCC | 29.66 | 27732954 | |
184 | Phosphorylation | DSRSSSPSDSDTSGF CCCCCCCCCCCCCCC | 52.25 | 18669648 | |
186 | Phosphorylation | RSSSPSDSDTSGFSS CCCCCCCCCCCCCCC | 47.31 | 27732954 | |
188 | Phosphorylation | SSPSDSDTSGFSSGS CCCCCCCCCCCCCCC | 34.40 | 28111955 | |
203 | Phosphorylation | DHLSDLISSLRISPP HHHHHHHHHCCCCCC | 30.53 | 24719451 | |
204 | Phosphorylation | HLSDLISSLRISPPL HHHHHHHHCCCCCCC | 18.05 | 25954137 | |
208 | Phosphorylation | LISSLRISPPLPFLS HHHHCCCCCCCCCEE | 17.65 | 29255136 | |
231 | Phosphorylation | PLKMGVGSRMDQEQA CCCCCCCCCCCHHHH | 23.25 | 28674151 | |
305 | Ubiquitination | QLPPRNYKNPIYSCK CCCCCCCCCCCEEEE | 60.85 | - | |
347 | Acetylation | EWPGKDGKHPRCPPK ECCCCCCCCCCCCCC | 61.64 | 7925751 | |
374 | Phosphorylation | ELEKSVRSLLQACSH EHHHHHHHHHHHHCC | 31.13 | 23879269 | |
380 | Phosphorylation | RSLLQACSHDPLSPD HHHHHHHCCCCCCCC | 33.66 | 23879269 | |
390 | Phosphorylation | PLSPDGLSEYYFKMS CCCCCCHHHHHHHHH | 29.14 | 23879269 | |
501 | Phosphorylation | EIKTTKFTKKVQIDP EEEECCCEEEEECCC | 31.35 | 29496963 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CPEB1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CPEB1_HUMAN | CPEB1 | physical | 22456264 | |
A4_HUMAN | APP | physical | 21832049 | |
MOT2_HUMAN | SLC16A7 | physical | 21988832 | |
SYMPK_HUMAN | SYMPK | physical | 28514442 | |
MAP12_HUMAN | METAP1D | physical | 28514442 | |
GBP5_HUMAN | GBP5 | physical | 28514442 | |
APBA3_HUMAN | APBA3 | physical | 28514442 | |
CSTFT_HUMAN | CSTF2T | physical | 28514442 | |
GAN_HUMAN | GAN | physical | 28514442 | |
NMD3_HUMAN | NMD3 | physical | 28514442 | |
CSTF2_HUMAN | CSTF2 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-43, AND MASSSPECTROMETRY. |